Cowie Robin Harper 4

4 · BIODESIX INC · Filed Feb 11, 2026

AI-generated summary of this filing

Updated Feb 11, 2026

BIODESIX (BDSX) CFO Robin Cowie Sells 941 Shares

What Happened

Robin Harper Cowie, CFO, Secretary & Treasurer of BIODESIX (BDSX), reported RSU vesting and related share transactions. On 2026-02-09, 2,584 restricted stock units (RSUs) converted to common shares (reported as an exercise/conversion, code M). The filing also shows two zero-dollar dispositions that same day totaling 2,584 shares (157 and 2,427 shares), and on 2026-02-10 the insider sold 941 shares in an open-market transaction at a weighted average price of $10.08 for proceeds of $9,489.
These transactions are routine tax- and vesting-related actions (not a new purchase). The zero-dollar disposals reflect shares withheld/disposed in connection with RSU settlement/tax withholding; the open-market sale generated the $9,489 in proceeds.

Key Details

Transaction dates & prices:
- 2026-02-09: 2,584 RSUs converted to 2,584 shares (code M; no cash price reported for conversion).
- 2026-02-09: Dispositions of 157 and 2,427 shares reported at $0.00 (derivative/withholding).
- 2026-02-10: Sale of 941 shares at weighted avg $10.08 — proceeds $9,489. Report notes sale prices on the transaction date ranged $9.94–$10.21.
Shares owned after the transactions: not specified in the information provided in this summary (see the filing for exact post-transaction holdings).
Notable footnotes from the filing:
- F1–F6: the shares arose from RSUs (each RSU = one share), vesting schedules described (quarterly installments from Feb 8, 2022, and annual installments from Feb 8, 2023), and figures adjusted for a 1-for-20 reverse split effective Sept 15, 2025.
- F2/F3: some shares were sold automatically by the issuer’s broker to cover taxes; the $10.08 price is a weighted average of multiple sales.
Filing timeliness: The Form 4 was filed on 2026-02-11 for transactions dated Feb 9–10; this appears to be timely (within the Form 4 reporting window).

Context

These were not buys; they were RSU conversions and tax-related disposals/sales. The derivative code (M) here reflects the conversion/settlement of restricted stock units into shares. The zero-dollar disposals typically indicate shares withheld or surrendered to satisfy tax withholding obligations rather than a market sale for proceeds.
Such tax-withholding sales and net settlements are common after vesting and do not necessarily signal a change in the insider’s view of the company.

Form 4

Period: 2026-02-09

CFO, Sec'y & Treasurer

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-09+2,584→ 16,238 total
Sale
Common Stock
[F2][F3]
2026-02-10$10.08/sh−941$9,489→ 15,297 total
Exercise/Conversion
Restricted Stock Units
[F1][F4]
2026-02-09−157→ 0 total
→ Common Stock (157 underlying)
Exercise/Conversion
Restricted Stock Units
[F1][F5][F6]
2026-02-09−2,427→ 2,426 total
→ Common Stock (2,427 underlying)

Footnotes (6)

[F1]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
[F2]These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
[F3]The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $9.94 to $10.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]These RSUs vested in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date.
[F5]These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025.
[F6]These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

Signature

/s/ Robin Harper Cowie|2026-02-11

1 file